June 29, 2026 · Form 4 insider transaction
Marshall Richard Henry bought 120,000 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.